Skip to main content

Prediction: This Growth Stock Could Double in 2023

Yahoo! Finance
Biotech company Axsome Therapeutics (NASDAQ: AXSM) has had a strong -- although somewhat volatile -- year on the stock market. Let's consider why Axsome Therapeutics' stock could crush the market again next year. Axsome Therapeutics earned approval for Auvelity in August.
Continue Reading